Human Chorionic Gonadotropin (hCG) maintains ovarian corpus luteum function in women, promotes progesterone and estrogen secretion by the corpus luteum, and supports early pregnancy stability. In men, it stimulates the synthesis and secretion of testosterone by testicular interstitial cells, aiding reproductive organ development and spermatogenesis. It is commonly used for luteal support following treatment for threatened miscarriage due to luteal insufficiency in women. It may also be employed as replacement therapy for male hypogonadism or combined with ovulation-inducing drugs to enhance female ovulation function and increase conception probability.

The peptide will be provided as lyophilized powder to ensure maximum stability.